Select Medical Holdings Corporation（NYSE: SEM）已达成最终协议，将由一个投资财团进行收购。该财团由公司现任执行董事长罗伯特·A·奥滕齐奥、首席执行官马丁·F·杰克逊以及领先的私募股权公司Welsh, Carson, Anderson & Stowe（WCAS）共同领导。
根据协议条款，收购财团将以每股特定现金价格收购其尚未持有的Select Medical所有流通股。此次交易彰显了财团对公司长期价值和发展潜力的坚定信心。
交易完成后，Select Medical将成为一家私人控股公司，其普通股将不再在纽约证券交易所公开交易。该交易预计将于2024年下半年完成，但需满足惯例成交条件，包括获得股东和监管机构的批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.